Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Recommended Immunization Schedules for Persons Aged 0--18 Years
--- United States, 2007
Please note:
An
erratum has been published for this article. To view the erratum, please
click here.
The Advisory Committee on Immunization Practices (ACIP) periodically reviews the recommended immunization
schedule for persons aged 0--18 years to ensure that the schedule is current with changes in vaccine formulations and
reflects revised recommendations for the use of licensed vaccines, including those newly licensed.
The changes to the previous childhood and adolescent
immunization schedule, published January 2006
(1), are as follows:
The new rotavirus vaccine (Rota) is recommended in a
3-dose schedule at ages 2, 4, and 6 months. The first dose
should be administered at ages 6 weeks through 12 weeks with subsequent doses administered at 4--10 week intervals.
Rotavirus vaccination should not be initiated for infants aged >12 weeks and should not be administered after age 32 weeks
(2).
The influenza vaccine is now recommended for all children aged 6--59 months
(3).
Varicella vaccine recommendations are updated. The first dose should be administered at age 12--15 months, and a
newly recommended second dose should be administered at age 4--6 years
(4).
The new human papillomavirus vaccine (HPV) is recommended in a 3-dose schedule with the second and third
doses administered 2 and 6 months after the first dose. Routine vaccination with HPV is recommended for
females aged 11--12 years; the vaccination series can be started in females as young as age 9 years; and a catch-up vaccination is
recommended for females aged 13--26 years who have not been vaccinated previously or who have not completed the full vaccine
series (5).
The main change to the format of the schedule is the division of the recommendation into two schedules: one
schedule for persons aged 0--6 years (Figure 1) and
another for persons aged 7--18 years (Figure 2). Special populations
are represented with purple bars; the 11--12 years
assessment is emphasized with the bold, capitalized fonts in the title of
that column. Rota, HPV, and varicella vaccines are incorporated in the catch-up
immunization schedule (Table).
Vaccine Information Statements
The National Childhood Vaccine Injury Act requires that health-care providers provide parents or patients with copies
of Vaccine Information Statements before administering each dose of the vaccines listed in the schedule. Additional
information is available from state health departments and from CDC at
http://www.cdc.gov/nip/publications/vis.
Detailed recommendations for using vaccines are available from package inserts, ACIP statements on specific vaccines,
and the 2003 Red Book (6). ACIP statements for each recommended childhood vaccine are available from CDC
at http://www.cdc.gov/nip/publications/acip-list.htm. In
addition, guidance for obtaining and completing a
Vaccine Adverse Event Reporting System form is available at
http://www.vaers.hhs.gov or by telephone, 800-822-7967.
American Academy of Pediatrics. Active and passive immunization. In: Pickering LK, ed. 2003 red book: report of the Committee on
Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003.
The recommended immunization schedules for persons aged 0--18 years and the catch-up immunization schedule for 2007 have been approved by the Advisory Committee
on Immunization Practices, the American Academy of Pediatrics, and the American Academy of Family Physicians. The standard
MMWR footnote format has been modified for publication
of this schedule.
Suggested citation: Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0--18 years---United States, 2007. MMWR 2006;55(51&52):Q1--Q4.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
